The following is from  Children’s Health Defense. Nirsevimab, marketed by Sanofi and AstraZeneca as Beyfortus  is a drug developed to protect infants from RSV (respiratory syncytial virus), a virus that can lead to serious respiratory infections. It was fast-tracked for approval by the US […]